1. Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies
   Giovanni Musso et al, 2016, Nature Reviews Drug Discovery CrossRef
2. MicroRNA-33a-3p suppresses cell migration and invasion by directly targeting PBX3 in human hepatocellular carcinoma
   Shu-Yan Han et al, 2106, Oncotarget CrossRef
3. MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma
   Laura Gramantieri et al, 2021, Journal of Hepatocellular Carcinoma CrossRef
4. APE1 controls DICER1 expression in NSCLC through miR-33a and miR-130b
   Giulia Antoniali et al, 2022, Cellular and Molecular Life Sciences CrossRef
5. Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration
   Eriseld Krasniqi et al, 2022, International Journal of Molecular Sciences CrossRef
6. Role of microRNA-33a in regulating the expression of PD-1 in lung adenocarcinoma
   Laura Boldrini et al, 2017, Cancer Cell International CrossRef
7. Downregulation of miR‑138‑5p promotes non‑small cell lung cancer progression by regulating CDK8
   Shigang Xing et al, 2019, Molecular Medicine Reports CrossRef
8. Molecular alterations in meningiomas: Literature review
   Benedito Jamilson Araújo Pereira et al, 2019, Clinical Neurology and Neurosurgery CrossRef
9. The effects of tracheal occlusion on Wnt signaling in a rabbit model of congenital diaphragmatic hernia
   Martina Mudri et al, 2019, Journal of Pediatric Surgery CrossRef
10. Expression of miRNA-21, miRNA-107, miRNA-137 and miRNA-29b in meningioma
    Salim Katar et al, 2017, Clinical Neurology and Neurosurgery CrossRef
11. MiR-1294 inhibits the progression of breast cancer via regulating ERK signaling
    Kejie Chen et al, 2022, Bulletin du Cancer CrossRef
12. Potential circulating miRNA signature for early detection of NSCLC
    Ayda Arab et al, 2017, Cancer Genetics CrossRef
13. Immunomodulatory MicroRNAs in cancer: targeting immune checkpoints and the tumor microenvironment
    Hany A. Omar et al, 2019, The FEBS Journal CrossRef
14. An approach to forecast human cancer by profiling microRNA expressions from NGS data
    A. Salim et al, 2017, BMC Cancer CrossRef
15. MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN
    Hongyan Wang et al, 2015, Journal of Experimental & Clinical Cancer Research CrossRef
16. miR-101 Promotes Degradation of Cartilage Matrix in Osteoarthritis
    Hao Cheng et al, 2022, Journal of Biomaterials and Tissue Engineering CrossRef
17. MiR-33a suppresses proliferation of NSCLC cells via targeting METTL3 mRNA
    Minjun Du et al, 2017, Biochemical and Biophysical Research Communications CrossRef
18. The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer
    Mingdi Zhang et al, 2016, Oncotarget CrossRef
19. MicroRNA-33a downregulation is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma
    Ru‑Ting Xie et al, 2018, Oncology Letters CrossRef
20. MiR-33a plays a crucial role in the proliferation of bovine preadipocytes
    Wenzhen Zhang et al, 2021, Adipocyte CrossRef
21. MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN
    Tao Yu et al, 2015, Oncotarget CrossRef
22. RETRACTED ARTICLE: Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma
    Shuang Wei et al, 2016, Cell Death & Disease CrossRef
23. Role of microRNA‑33a in malignant cells (Review)
    Chang Gao et al, 2020, Oncology Letters CrossRef
24. Brain Invasion and Trends in Molecular Research on Meningioma
    Kyeong-O Go et al, 2023, Brain Tumor Research and Treatment CrossRef
25. Focus on PD-1/PD-L1 as a Therapeutic Target in Ovarian Cancer
    Adrian Dumitru et al, 2022, International Journal of Molecular Sciences CrossRef